Literature DB >> 8963392

Hypogonadism is not related to the etiology of liver cirrhosis.

S Kaymakoğlu1, A Okten, Y Cakaloğlu, G Boztaş, F Beşişik, C Taşçioğlu, S Yalçin.   

Abstract

We investigated the clinical and laboratory findings of hypogonadism and feminization in male patients with viral or alcoholic cirrhosis to determine whether chronic liver disease plays a primary role in the development of sexual dysfunction and hormonal changes. Two groups of male patients with liver cirrhosis (23 alcoholic, 33 viral) age- and Child's grade-matched, and 20 age-matched healthy men, as a control group, were included in this study. Clinical signs of hypogonadism and feminization were examined in the cirrhotic patients. Follicle-stimulating hormone, luteinizing hormone, prolactin, testosterone, free testosterone, estradiol, androstenedione, dehydroepiandrosterone sulfate, and sex hormone-binding globulin were estimated in all groups. Seminal fluid was also analyzed in 7 alcoholic and 15 viral cirrhotics. Serum levels of estradiol, androstenedione, and sex hormone-binding globulin were significantly higher, and free testosterone and dehydroepiandrosterone sulfate levels were significantly lower in both groups of cirrhotics compared with the control group. Child's C patients in both groups of cirrhotics were found to have higher estradiol and lower free testosterone levels than child's A and B patients. Alcoholic and viral cirrhotics had markedly reduced sperm motility and density. The differences between alcoholic and viral cirrhotic patients in the clinical signs of hypogonadism, serum levels of sex steroids, and the results of seminal fluid analysis were not statistically significant. These findings suggest that liver cirrhosis per se, independent of etiology, causes hypogonadism and feminization, and that the degree of hypogonadism and feminization correlates well with the severity of liver failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8963392     DOI: 10.1007/bf02349641

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  24 in total

1.  Hypogonadism in chronic liver disease: impaired release of luteinising hormone.

Authors:  P Bannister; T Handley; C Chapman; M S Losowsky
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

2.  Gonadal dysfunction and inadequate sexual performance in alcoholic cirrhotic men.

Authors:  J S Gavaler; D H Van Thiel
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

3.  Estrogen-androgen imbalance in hepatic cirrhosis. Studies in 13 male patients.

Authors:  I J Chopra; D Tulchinsky; F L Greenway
Journal:  Ann Intern Med       Date:  1973-08       Impact factor: 25.391

4.  Plasma testosterone, estradiol, and gonadotrophins in hepatic insufficiency.

Authors:  J R Kent; R J Scaramuzzi; W Lauwers; A F Parlow; M Hill; R Penardi; J Hilliard
Journal:  Gastroenterology       Date:  1973-01       Impact factor: 22.682

5.  Hypothalamic-pituitary-gonadal function in men with cirrhosis of the liver.

Authors:  N A Mowat; C R Edwards; R Fisher; A S McNeilly; J R Green; A M Dawson
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

6.  Mechanism of hypogonadism in cirrhotic males.

Authors:  G R Green
Journal:  Gut       Date:  1977-10       Impact factor: 23.059

7.  Gynecomastia in a hospitalized male population.

Authors:  C B Niewoehner; F Q Nuttal
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

8.  Patterns of hypothalamic-pituitary-gonadal dysfunction in men with liver disease due to differing etiologies.

Authors:  D H van Thiel; J S Gavaler; J A Spero; K M Egler; C Wright; A T Sanghvi; U Hasiba; J H Lewis
Journal:  Hepatology       Date:  1981 Jan-Feb       Impact factor: 17.425

9.  Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men.

Authors:  Y J Wang; J C Wu; S D Lee; Y T Tsai; K J Lo
Journal:  Hepatogastroenterology       Date:  1991-12

10.  Sexual dysfunction in men with alcoholic liver cirrhosis. A comparative study.

Authors:  S B Jensen; C Gluud
Journal:  Liver       Date:  1985-04
View more
  9 in total

1.  Effect of liver dysfunction on circulating sclerostin.

Authors:  Yumie Rhee; Won Jin Kim; Ki Jun Han; Sung Kil Lim; Se Hwa Kim
Journal:  J Bone Miner Metab       Date:  2013-10-15       Impact factor: 2.626

2.  Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role?

Authors:  A Gaudio; A Lasco; N Morabito; M Atteritano; C Vergara; A Catalano; W Fries; A Trifiletti; N Frisina
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

3.  MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease.

Authors:  Rebecca Mitchell; Jill McDermid; Mang M Ma; Constance L Chik
Journal:  World J Hepatol       Date:  2011-06-27

4.  Quantitative Analysis of Sex-Hormone-Binding Globulin Glycosylation in Liver Diseases by Liquid Chromatography-Mass Spectrometry Parallel Reaction Monitoring.

Authors:  Wei Yuan; Julius Benicky; Renhuizi Wei; Radoslav Goldman; Miloslav Sanda
Journal:  J Proteome Res       Date:  2018-07-16       Impact factor: 4.466

Review 5.  Hepatitis B virus infection and pregnancy: a practical approach.

Authors:  Ashish Kumar
Journal:  Indian J Gastroenterol       Date:  2012-04-21

6.  Prevalence and risk factors of erectile dysfunction in patients with liver cirrhosis: a systematic review and meta-analysis.

Authors:  Hye Jin Yoo; Bora Lee; Eun-Ae Jung; Sang Gyune Kim; Young Seok Kim; Jeong-Ju Yoo
Journal:  Hepatol Int       Date:  2021-11-20       Impact factor: 6.047

7.  Osteoporosis in chronic liver disease: a case-control study.

Authors:  Ghizlane Wariaghli; Aziza Mounach; Lahsen Achemlal; Imane Benbaghdadi; Aziz Aouragh; Ahmed Bezza; Abdellah El Maghraoui
Journal:  Rheumatol Int       Date:  2009-07-28       Impact factor: 2.631

8.  Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease.

Authors:  Céline Jouffe; Benjamin D Weger; Eva Martin; Florian Atger; Meltem Weger; Cédric Gobet; Divya Ramnath; Aline Charpagne; Delphine Morin-Rivron; Elizabeth E Powell; Matthew J Sweet; Mojgan Masoodi; N Henriette Uhlenhaut; Frédéric Gachon
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 12.779

Review 9.  Structural changes of proteins in liver cirrhosis and consequential changes in their function.

Authors:  Nikola Gligorijević; Simeon Minić; Olgica Nedić
Journal:  World J Gastroenterol       Date:  2022-08-07       Impact factor: 5.374

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.